Skip to content


You currently have no items in your basket.

Jellagen Marine Biotechnologies

Jellagen, an innovative marine biotechnology company was co-founded in 2013 by Prof. Andrew Mearns Spragg, a Scottish marine biotechnology pioneer. The idea first came to him whilst surfing off the East coast of Scotland in his youth swimming through blooms of jellyfish. Since 2013, Jellagen has secured considerable investment from both private investors and public sources to develop its business. In 2018, Jellagen has commercialised its jellyfish collagen cell culture products for research, achieved ISO13485 certification for their collagen manufacturing processes and by the end of 2018, the company will employ >12 people.


To view all products from Jellagen, please click on the link below!

Click Here
Jellagen® 3D Scaffolds

Jellagen® 3D Scaffolds

Next Generation Jellyfish Collagen 3D Scaffolds for in vitro cell culture
and tissue engineering.

Click Here
What does the future of cell culture look like ?

What does the future of cell culture look like ?

What if there was a next generation collagen alternative that could make your cells happy again? With this white paper, we will guide you through the future of cell culture protein.

Click Here
Test Jellyfish Collagen in your own lab!

Test Jellyfish Collagen in your own lab!

Advance your cell culture research by joining their free trial programme and receive either; 4 individually cast 3D Scaffolds, or 96 well collagen coated plates for you to test in your own lab!

Click Here


Collagen is the most abundant protein in mammals and is found in skin, cartilage, bone, intervertebral discus, blood vessels, tendons, ligaments, cornea and is a key protein component of the Extra Cellular Matrix (ECM). Collagen is therefore regarded as the building block of tissue. Fibrillar collagens in particular are the more abundant extracellular proteins. They form a metazoan-specific family, and are highly conserved from sponge to human.

For many decades, collagen extracted from mammalian (pigs, cows, sheep) have been successfully used in the food, cosmetic, medical device and pharmaceutical industries. However due to rising safety concerns around use of mammalian derived products (viral disease vectors and BSE), safer alternatives are being sought. Jellyfish offer that safer and disease-free alternative.

Jellyfish first evolved on earth some 600 million years ago and are often referred to as Gelatinous Zooplankton. They are abundant in supply and an evolutionary ancient form of collagen. Jellagen is pioneering the manufacture and development of a next generation collagen for the use in medical device.

Jellyfish collagen is an evolutionary ancient chemical template and is where all collagens up the tree of life have been derived. Jellyfish collagen is in essence, the root of all collagens, compatible with a broad range of cell types making it an ideal biomaterial for medical devices.

The value proposition of the company is based on the unique selling features of jellyfish collagen scaffolds which are:

  • Evolutionary ancient chemistry offering a next generation collagen biomaterial able to provide distinctive functional advantages over mammalian collagens.
  • Lower immunogenicity than mammalian sourced materials allowing for the potential of transferring direct in vivo analytical results into in vivo applications, providing a significant opportunity for accuracy in clinical development.
  • Batch to batch product consistency compared to mammalian collagen.
  • A disease vector (BSE) free collagen

Jellagen believes that its next generation jellyfish derived collagen can address all the existing collagen market today with its unique positioning and comparable cost.

This website uses cookies. For more information about these please click here.
By continuing to browse you consent to the use of cookies